| Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer H Zeng, S Umar, B Rust, D Lazarova, M Bordonaro International journal of molecular sciences 20 (5), 1214, 2019 | 336 | 2019 |
| Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention H Zeng, DL Lazarova, M Bordonaro World journal of gastrointestinal oncology 6 (2), 41, 2014 | 316 | 2014 |
| Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation JM Mariadason, M Bordonaro, F Aslam, L Shi, M Kuraguchi, A Velcich, ... Cancer research 61 (8), 3465-3471, 2001 | 216 | 2001 |
| Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? M Bordonaro, DL Lazarova, AC Sartorelli Cell Cycle 7 (9), 1178-1183, 2008 | 148 | 2008 |
| Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the β-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin M Bordonaro, JM Mariadason, F Aslam, BG Heerdt, LH Augenlicht | 120 | 1999 |
| Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate DL Lazarova, M Bordonaro, R Carbone, AC Sartorelli International journal of cancer 110 (4), 523-531, 2004 | 117 | 2004 |
| The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors M Bordonaro, DL Lazarova, AC Sartorelli Experimental cell research 313 (8), 1652-1666, 2007 | 102 | 2007 |
| A faster ribonuclease protection assay. CF Saccomanno Biotechniques 13, 846-850, 1992 | 87 | 1992 |
| A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells M Bordonaro, S Tewari, CE Cicco, W Atamna, DL Lazarova PLoS One 6 (11), e27308, 2011 | 74 | 2011 |
| Vimentin, colon cancer progression and resistance to butyrate and other HDAC is DL Lazarova, M Bordonaro Journal of cellular and molecular medicine 20 (6), 989-993, 2016 | 71 | 2016 |
| CBP activity mediates effects of the histone deacetylase inhibitor butyrate on WNT activity and apoptosis in colon cancer cells DL Lazarova, C Chiaro, T Wong, E Drago, A Rainey, S O'Malley, ... Journal of Cancer 4 (6), 481, 2013 | 66 | 2013 |
| Transcriptional Regulation of the Vitamin D3 Receptor Gene by ZEB DL Lazarova, M Bordonaro, AC Sartorelli | 64 | 2001 |
| CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer M Bordonaro, DL Lazarova World journal of gastroenterology: WJG 21 (27), 8238, 2015 | 60 | 2015 |
| Quantum biology at the cellular level—Elements of the research program M Bordonaro, V Ogryzko Biosystems 112 (1), 11-30, 2013 | 55 | 2013 |
| Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer? M Bordonaro, DL Lazarova, AC Sartorelli Oncology research 17 (1), 1-9, 2008 | 54 | 2008 |
| An improved T1/A ribonuclease protection assay M Bordonaro, CF Saccomanno, JL Nordstrom BioTechniques 16 (3), 428-430, 1994 | 54 | 1994 |
| Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells DL Lazarova, C Chiaro, M Bordonaro BMC research notes 7, 1-8, 2014 | 52 | 2014 |
| Cell type‐and promoter‐dependent modulation of the Wnt signaling pathway by sodium butyrate M Bordonaro, DL Lazarova, LH Augenlicht, AC Sartorelli International journal of cancer 97 (1), 42-51, 2002 | 49 | 2002 |
| ZEB1 mediates drug resistance and EMT in p300-deficient CRC D Lazarova, M Bordonaro Journal of Cancer 8 (8), 1453, 2017 | 47 | 2017 |
| The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways M Bordonaro, S Tewari, W Atamna, DL Lazarova Experimental cell research 317 (10), 1368-1381, 2011 | 41 | 2011 |
